Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.

Saulnier, Mark G; Balasubramanian, Balu N; Long, Byron H; Frennesson, David B; Ruediger, Edward; Zimmermann, Kurt; Eummer, Jeffrey T; St Laurent, Denis R; Stoffan, Karen M; Naidu, B Narasimhulu; Mahler, Mikael; Beaulieu, Francis; Bachand, Carol; Lee, Frank Y; Fairchild, Craig R; Stadnick, Linda K; Rose, William C; Solomon, Carola; Wong, Henry; Martel, Alain; Wright, John J; Kramer, Robert; Langley, David R; Vyas, Dolatrai M

Saulnier, Mark G; Balasubramanian, Balu N; Long, Byron H; Frennesson, David B; Ruediger, Edward; Zimmermann, Kurt; Eummer, Jeffrey T; St Laurent, Denis R; Stoffan, Karen M; Naidu, B Narasimhulu; Mahler, Mikael; Beaulieu, Francis; Bachand, Carol; Lee, Frank Y; Fairchild, Craig R; Stadnick, Linda K; Rose, William C; Solomon, Carola; Wong, Henry; Martel, Alain; Wright, John J; Kramer, Robert; Langley, David R; Vyas, Dolatrai M.

Affiliation

Saulnier MG; The Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, USA. Mark.Saulnier@bms.com

J Med Chem ; 48(7): 2258-61, 2005 Apr 07.

Article de En | MEDLINE | ID: mdl-15801816

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Camptothécine / Carbazoles / Glucosides / Indoles / Antinéoplasiques Limites: Animals / Humans Langue: En Journal: J Med Chem Sujet du journal: QUIMICA Année: 2005 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links